window-to-japan.eu

Window to Japan

OncoTherapy Science announces stop of phase III study on COMPETE-PC, its pancreatic cancer-directed cocktail vaccine C01

By schmid_wordpressPosted on Posted in News

Clinical efficacy is not sufficiently higher as compared to control group.

OncoTherapy Science press release, December 20, 2013

OncoTherapy Science announces stop of phase III study on COMPETE-PC, its pancreatic cancer-directed cocktail vaccine C01
Scroll to top